Asia Pacific Drug Delivery Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Inhalers, Injection Devices, Implants, Transdermal Patches, and Others), By Application (Oncology, Infectious Diseases, Respiratory Diseases, Diabetes, and Others), By End Use (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, and Others), and Asia Pacific Drug Delivery Devices Market Insights, Industry Trend, Forecasts to 2035

• Asia Pacific Drug Delivery Devices Market Insights Forecasts to 2035
• The Asia Pacific Drug Delivery Devices Market Size was estimated at USD 91.5 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.54% from 2025 to 2035
• The Asia Pacific Drug Delivery Devices Market Size is Expected to Reach USD 203.5 Billion by 2035

The Asia Pacific Drug Delivery Devices Market is anticipated to reach USD 203.5 billion by 2035, growing at a CAGR of 7.54% from 2025 to 2035. The increasing adoption of innovative technology in medical devices, along with an increasing awareness about self-medication, is driving the drug delivery devices market in the Asia Pacific region.

Market Overview

The Asia Pacific drug delivery devices market is the industry encompassing the development, manufacturing, and distribution of medical devices used for administering drugs and other therapeutic substances into the body. Drug delivery devices are prefabricated systems intended to release the drug to the desired organ with maximum safety, effectiveness, and reliability. There is an increasing adoption of advanced technology for precise drug delivery, which is escalating the drug delivery devices market. Drug delivery devices are used for treating conditions like asthma, COPD, diabetes, cancer, and chronic pain. Further, the device ensures precise, targeted delivery of medications, improving efficacy and patient compliance with minimum side effects. Technological advancements in drug delivery systems are escalating the market growth opportunity for drug delivery devices.

Coverage

This research report categorizes the market for the Asia Pacific drug delivery devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Asia Pacific drug delivery devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Asia Pacific drug delivery devices market.

Driving Factors

The market for Asia Pacific drug delivery devices is primarily driven by the emergence of innovative technology, such as nanotechnology, for delivering drugs to targeted tissues or cells with increased precision and reduced side effects. An increasing awareness about self-medication for driving by the need for patient convenience, along with an increasing prevalence of chronic diseases, is contributing to the market demand for drug delivery devices.  

Restraining Factors

The risk associated with needlestick injuries, as well as the increased cost of development & manufacturing, are limiting its adoption, thereby restraining the market growth. Further, the stringent rules and regulations associated with novel device approval are challenging the market.

Market Segmentation

The Asia Pacific drug delivery devices market share is classified into product, application, and end use.

• The inhalers segment held the dominant market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific drug delivery devices market is segmented by product into inhalers, injection devices, implants, transdermal patches, and others. Among these, the inhalers segment held the dominant market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The emergence of smart inhaler technology that provides various benefits, including patient dose tracking, is driving the market growth in the inhalers segment.

• The diabetes segment dominated the drug delivery devices market in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific drug delivery devices market is segmented by application into oncology, infectious diseases, respiratory diseases, diabetes, and others. Among these, the diabetes segment dominated the drug delivery devices market in 2024 and is expected to grow at a significant CAGR during the forecast period. There is an increasing development of fully automated systems to mimic insulin delivery by the pancreas and reduce invasiveness during drug administration.

•  The hospitals segment dominated the market with the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Asia Pacific drug delivery devices market is segmented by end use into hospitals, diagnostic centers, ambulatory surgery centers/clinics, and others. Among these, the hospitals segment dominated the market with the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. An increasing adoption of cutting-edge equipment by medical professionals for better therapeutic outcomes and improved patient experience, along with an increasing number of surgeries, is propelling the market growth in the hospitals segment.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Asia Pacific drug delivery devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Terumo Corporation
• Nipro Corporation
• Ypsomed
• Shinva Medical Instrument Co., Ltd.
• Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Asia Pacific, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Asia Pacific Drug Delivery Devices Market based on the below-mentioned segments:

Asia Pacific Drug Delivery Devices Market, By Product

• Inhalers
• Injection Devices
• Implants
• Transdermal Patches
• Others

Asia Pacific Drug Delivery Devices Market, By Application

• Oncology
• Infectious Diseases
• Respiratory Diseases
• Diabetes
• Others

Asia Pacific Drug Delivery Devices Market, By End Use

• Hospitals
• Diagnostic Centers
• Ambulatory Surgery Centers/Clinics
• Others